MoleMate is Easy for Physicians to Incorporate Into Physical Exams

Oct. 17, 2011 - PRLog -- MoleMate is easy to incorporate into exams, and is easy for physicians to learn how to use as documented in a study with general practitioners, who significantly improved their ability to more accurately identify suspicious moles and lesion.
MoleMate uses a hand-held device designed for office use that utilizes light to view beneath suspicious moles in a pain free, non-invasive manner, creating images for physicians to evaluate moles and lesions often eliminating the need for skin biopsies resulting in less pain, scarring, and expense.
The FDA approved MoleMate and SIMSYS Skin Imaging Systems are a significant advance in the early detection of potentially life threatening moles and lesions.  MoleMate and SIMSYS rapidly provide accurate images of the pigment, blood, and collagen below the mole or lesion.

The Skin Cancer Foundation states that skin cancer is the most common form of cancer in the US. Each year there are more new cases of skin cancer than the combined incidence of cancers of the breast, prostrate, lung and colon.

There are several types of skin cancers. Nearly 13 million people in the US are living with a history of non-melanoma skin cancer, typically diagnosed as basal cell carcinoma or squamous cell carcinoma. 800,000 people in the US are living with a history of melanoma. The survival rate for patients whose melanoma is detected early, before the tumor has penetrated the skin, is about 99 percent. The survival rate falls to 15 percent for those with advanced disease

“Among the sophisticated equipment used by University of California Irvine Melanoma Center physicians is a SIMSYS-MoleMate SIAscope, one of the most advanced melanoma imaging systems in the world. For patients with many moles, this computer imaging can make a big difference, it decreases the number of biopsies needed, so they won’t look like a pincushion.”- Dr. James G. Jakowatz, surgical oncologist and UC Irvine Melanoma Center director – Dr. Janellen Smith, UC Irvine dermatologist and co-director of the Pigmented Lesion Program, UC Irvine.

MoleMate and the more robust system, SIMSYS, work with a hand-held scanner, designed for office use, along with a specially designed training CD. SIMSYS allows image capture and storage as well as special features that can be used in visualizing and comparing moles.

The website http://simsys-molemate.com contains additional information on MoleMate and SIMSYS, including information on the technology behind these products, siascopy, as well as product demos, and information on how other physicians have integrated the skin cancer imaging system into their practice.

MoleMate and SIMSYS will also be presented at theAmericanAcademy of Dermatology’s 70thAnnual Meeting, March 16-22, 2012, inSan Diego,California, the world’s largest, most comprehensive dermatologic educational event.   Work with MoleMate and SIMSYS at booth #1361.

About SIMSYS-MoleMate
The FDA approved SIMSYS-MoleMate Skin Imaging System, a non-invasive skin cancer screening procedure, is a significant advance in the early detection of potentially life threatening moles and lesions.

Physicians have found the SIMSYS-MoleMate Siascope hand-held device easy to learn and use, and that it rapidly provides accurate images of the pigment, blood, and collagen below the mole or lesion.
Now, for the first time, physicians can more accurately evaluate suspicious moles and lesions in a non-invasive, pain-free way. Experts also believe it may reduce the need for time consuming and expensive biopsies.

Physicians interested in learning more should contact
SIMSYS-MoleMate
MedX Health Corp.
(905) 670-4428
(888) 363-3112
info@medxhealth.com
www.simsys-molemate.com

# # #

SOS eMarketing is an integrated eMarketing firm. We work with small businesses to increase their sales and profits.